135 related articles for article (PubMed ID: 11442266)
1. Incorporation of the model drug ubidecarenone into solid lipid nanoparticles.
Bunjes H; Drechsler M; Koch MH; Westesen K
Pharm Res; 2001 Mar; 18(3):287-93. PubMed ID: 11442266
[TBL] [Abstract][Full Text] [Related]
2. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
3. Preparation and physicochemical characterization of aqueous dispersions of coenzyme Q10 nanoparticles.
Siekmann B; Westesen K
Pharm Res; 1995 Feb; 12(2):201-8. PubMed ID: 7784334
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.
Zimmermann E; Souto EB; Müller RH
Pharmazie; 2005 Jul; 60(7):508-13. PubMed ID: 16076076
[TBL] [Abstract][Full Text] [Related]
5. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
6. Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10).
Nanjwade BK; Kadam VT; Manvi FV
J Biomed Nanotechnol; 2013 Mar; 9(3):450-60. PubMed ID: 23621001
[TBL] [Abstract][Full Text] [Related]
7. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
[TBL] [Abstract][Full Text] [Related]
9. Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.
Kuntsche J; Westesen K; Drechsler M; Koch MH; Bunjes H
Pharm Res; 2004 Oct; 21(10):1834-43. PubMed ID: 15553230
[TBL] [Abstract][Full Text] [Related]
10. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Teeranachaideekul V; Souto EB; Junyaprasert VB; Müller RH
Eur J Pharm Biopharm; 2007 Aug; 67(1):141-8. PubMed ID: 17346953
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study.
Jores K; Mehnert W; Mäder K
Pharm Res; 2003 Aug; 20(8):1274-83. PubMed ID: 12948026
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
Garcia-Fuentes M; Alonso MJ; Torres D
J Colloid Interface Sci; 2005 May; 285(2):590-8. PubMed ID: 15837476
[TBL] [Abstract][Full Text] [Related]
13. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.
Bunjes H; Koch MH
J Control Release; 2005 Oct; 107(2):229-43. PubMed ID: 16023752
[TBL] [Abstract][Full Text] [Related]
14. Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release.
Xia D; Cui F; Gan Y; Mu H; Yang M
J Pharm Sci; 2014 Feb; 103(2):697-705. PubMed ID: 24375427
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles.
Noack A; Hause G; Mäder K
Int J Pharm; 2012 Feb; 423(2):440-51. PubMed ID: 22197758
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
17. Drug release studies from lipid nanoparticles in physiological media by a new DSC method.
Roese E; Bunjes H
J Control Release; 2017 Jun; 256():92-100. PubMed ID: 28450207
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
19. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
Schubert MA; Harms M; Müller-Goymann CC
Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
